Wed, 10 Sep 2014 | BUSINESS SALE
The London start-up behind the Little Printer, Berg, is preparing to enter “hibernation” and plans to shut down by March 2015 if a buyer can’t be found.
The Little Printer, which retails for up to £149 a unit, is a small device that connects up to the internet and allows users to print off news and social media messages onto receipt-sized rolls of paper. It has succeeded in selling thousands of the units across the globe since 2012, when the business was set up.
In regards to the eventual closure Berg said it hadn’t been able to reach a “sustainable business in connected products”. “We’re wrapping up for this incarnation,” the company’s chief executive Matt Webb said in a blog post.
The company indicated that it is searching for a new owner for the Little Printer, and that it would be particularly looking for a business that “could commit to supporting and developing it. That means having hardware, software, and service capabilities, and being able to put resources into the product”.
Berg is to retain minimal levels of staff until March 2015 to keep the Little Printer operation ticking along.
Berg itself is a British design consultancy, a technology start-up that grew in the “silicon roundabout” in east London and was established in 2005. It was given over $1 million in investment backing from companies including Connect Ventures, Index Ventures and Initial Capital.
________________________________________________________________
Related information:
Technology businesses for sale
Business acquisitions: market awareness is everything
This unique and renowned freehold bar and restaurant in the heart of York City Centre offers over 250 covers across its spacious interior, pavement seating, and a rare rooftop terrace.
FREEHOLD
A well established and strongly profitable engineering business, located in the Midlands. The company will be an attractive acquisition for both a larger trade buyer and also those looking for a stable engineering business.
This European pharmacy manufacturer specialises in providing custom clinical trial batches for leading pharmacy companies across the continent, playing a crucial role in their R&D efforts.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.